Stock listing

Heidelberg Pharma Ag

Selected listing: HPHAD · AQUISUK · EUR · GB

Heidelberg Pharma Ag (Aquis:HPHAD), Health Technology. Latest release Sep 24, 2026: Heidelberg Pharma Presented New Clinical Data for Lead ATAC Candidate…

HPHAD:AQUISUKEURGBUpdated September 25, 2026

Ticker: Aquis:HPHAD
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Aquis
Currency: EUR

Latest news from Heidelberg Pharma Ag

Heidelberg Pharma Presented New Clinical Data for Lead ATAC Candidate Pamlectabart Tismanitin at IMS Annual Meeting 2026

September 24, 2026

Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026

September 7, 2026

Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates

August 28, 2026

Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

August 26, 2026

Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business

July 15, 2026

All Heidelberg Pharma Ag news →

Research Heidelberg Pharma Ag

Heidelberg Pharma Ag company profile

View the public company page for Heidelberg Pharma Ag on 6ix.

Heidelberg Pharma Ag news

Read company news and market updates connected to Heidelberg Pharma Ag.

Heidelberg Pharma Ag investor events

Find investor webinars, events, and replay context for Heidelberg Pharma Ag.